{
  "trial_id": "NCT01524991",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, prior radiation therapy, prior neoadjuvant/adjuvant therapy, prior intravesical therapy, presence of CNS metastases, history of autoimmune disease, history of prior malignancy, baseline renal function, baseline liver function, baseline hematologic parameters, baseline comorbidities, baseline infection status (HIV, Hepatitis B, Hepatitis C), baseline corticosteroid use, pregnancy status (for women of childbearing potential), method of contraception (for men of fathering potential).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Karnovsky Performance Status"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "prior radiation therapy",
        "prior neoadjuvant/adjuvant therapy",
        "prior intravesical therapy",
        "presence of CNS metastases",
        "history of autoimmune disease",
        "history of prior malignancy",
        "baseline renal function",
        "baseline liver function",
        "baseline hematologic parameters",
        "baseline comorbidities",
        "baseline infection status (HIV, Hepatitis B, Hepatitis C)",
        "baseline corticosteroid use",
        "pregnancy status (for women of childbearing potential)",
        "method of contraception (for men of fathering potential)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Histological or cytological proof of urothelial carcinoma, Clinical stage, Prior radiation therapy, Pregnancy status, Prior autoimmune disease, Prior malignancy, Prior systemic chemotherapy, Prior neoadjuvant/adjuvant therapy, Prior intravesical therapy, Underlying medical or psychiatric condition, Chronic infection status, Chronic systemic corticosteroids usage,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Karnovsky Performance Status"
      ],
      "remaining_candidate_features": [
        "Histological or cytological proof of urothelial carcinoma",
        "Clinical stage",
        "Prior radiation therapy",
        "Pregnancy status",
        "Prior autoimmune disease",
        "Prior malignancy",
        "Prior systemic chemotherapy",
        "Prior neoadjuvant/adjuvant therapy",
        "Prior intravesical therapy",
        "Underlying medical or psychiatric condition",
        "Chronic infection status",
        "Chronic systemic corticosteroids usage"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological proof of urothelial carcinoma, Prior radiation therapy, Prior systemic chemotherapy, Prior neoadjuvant/adjuvant therapy, Prior intravesical therapy, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Karnovsky Performance Status"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "ECOG Performance Status",
        "Histological proof of urothelial carcinoma",
        "Prior radiation therapy",
        "Prior systemic chemotherapy",
        "Prior neoadjuvant/adjuvant therapy",
        "Prior intravesical therapy",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological subtype of urothelial carcinoma, primary tumor location, number and location of metastatic sites, prior radiation therapy, prior neoadjuvant/adjuvant therapy, prior intravesical therapy, BMI, smoking status, medical history (including autoimmune diseases, chronic infections, and other relevant conditions).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Karnovsky Performance Status"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "histological subtype of urothelial carcinoma",
        "primary tumor location",
        "number and location of metastatic sites",
        "prior radiation therapy",
        "prior neoadjuvant/adjuvant therapy",
        "prior intravesical therapy",
        "BMI",
        "smoking status",
        "medical history (including autoimmune diseases, chronic infections, and other relevant conditions)"
      ]
    }
  }
}